Stockscreener 앱 받기
13.64
0.44%
0.06
시간 외 거래:
13.64
전일 마감가:
$13.58
열려 있는:
$13.63
하루 거래량:
99,309
Relative Volume:
0.36
시가총액:
$330.96M
수익:
$47.26M
순이익/손실:
$-58.48M
주가수익비율:
-5.0427
EPS:
-2.7049
순현금흐름:
$-40.45M
1주 성능:
+3.57%
1개월 성능:
-9.28%
6개월 성능:
+16.09%
1년 성능:
-53.84%
1일 변동 폭
$13.40
$13.93
1주일 범위
$12.49
$13.93
52주 변동 폭
$6.40
$30.62
Cvrx Inc Stock (CVRX) Company Profile
명칭
Cvrx Inc
전화
(763) 416-2850
주소
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
CVRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
13.64 | 330.96M | 47.26M | -58.48M | -40.45M | -2.7049 |
|
ABT
Abbott Laboratories
|
113.83 | 197.43B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
361.52 | 137.82B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
90.69 | 133.66B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
80.95 | 103.80B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
73.91 | 43.59B | 6.60B | 4.16B | 490.10M | 6.93 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-07-11 | 재확인 | Lake Street | Buy |
| 2024-05-01 | 재개 | Craig Hallum | Buy |
| 2024-05-01 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-05-01 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | 개시 | Lake Street | Buy |
| 2022-07-18 | 개시 | Craig Hallum | Buy |
| 2021-07-26 | 개시 | Canaccord Genuity | Buy |
| 2021-07-26 | 개시 | Piper Sandler | Overweight |
| 2021-07-26 | 개시 | William Blair | Outperform |
모두보기
Cvrx Inc 주식(CVRX)의 최신 뉴스
Trend Tracker for (CVRX) - Stock Traders Daily
State Street Corp Buys 27,071 Shares of CVRx, Inc. (NASDAQ:CVRX) - Defense World
Institutions own 39% of CVRx, Inc. (NASDAQ:CVRX) shares but private equity firms control 39% of the company - Yahoo Finance
Does CVRx (NASDAQ:CVRX) Have A Healthy Balance Sheet? - Simply Wall St
Fmr LLC Has $30,000 Position in CVRx, Inc. (NASDAQ:CVRX) - Defense World
(CVRX) Pivots Trading Plans and Risk Controls - Stock Traders Daily
CVRx to Present at J.P. Morgan Healthcare Conference 2025Key Industry Event - StockTitan
CVRx to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
CVRx's SWOT analysis: barostim maker's stock faces reimbursement crossroads - Investing.com
FY2026 Earnings Estimate for CVRx Issued By William Blair - MarketBeat
What is William Blair’s Forecast for CVRx FY2026 Earnings? - Defense World
Learn to Evaluate (CVRX) using the Charts - Stock Traders Daily
CVRx, Inc. (NASDAQ:CVRX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
CVRx's SWOT analysis: barostim maker's stock faces reimbursement hurdles By Investing.com - Investing.com Nigeria
CVRx's SWOT analysis: barostim maker's stock faces reimbursement hurdles - Investing.com
Evaluating CVRx: Insights From 6 Financial Analysts - Inkl
CVRx (NASDAQ:CVRX) Given New $22.00 Price Target at Canaccord Genuity Group - MarketBeat
Cvrx (CVRX) Declined Due To Turbulence In The Direct Sales Team - MSN
Cantor Fitzgerald Increases Earnings Estimates for CVRx - Defense World
FY2024 EPS Estimates for CVRx Lifted by Cantor Fitzgerald - MarketBeat
Parkman Healthcare Partners LLC Has $6.02 Million Stock Position in CVRx, Inc. (NASDAQ:CVRX) - MarketBeat
PDT Partners LLC Acquires New Position in CVRx, Inc. (NASDAQ:CVRX) - MarketBeat
CVRx Insiders May Regret Not Buying More, Market Cap Hits US$377m - Simply Wall St
(CVRX) Trading Report - Stock Traders Daily
Paul Verrastro Sells 1,430 Shares of CVRx, Inc. (NASDAQ:CVRX) Stock - MarketBeat
CVRx chief marketing officer Paul Verrastro sells $19,416 in stock By Investing.com - Investing.com Nigeria
CVRx chief marketing officer Paul Verrastro sells $19,416 in stock - Investing.com
CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference - GlobeNewswire
CVRx to Present at Piper Sandler 36th Annual Healthcare Conference in December | CVRX Stock News - StockTitan
CVRx, Inc. (NASDAQ:CVRX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
CVRx, Inc. (NASDAQ:CVRX) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
CVRx’s Barostim Gains New CPT Codes - MPO-mag
(CVRX) Long Term Investment Analysis - Stock Traders Daily
International Assets Investment Management LLC Makes New Investment in CVRx, Inc. (NASDAQ:CVRX) - MarketBeat
CVRx: Impressive Top-Line Growth Seems Priced In - Seeking Alpha
Cantor Fitzgerald Initiates Coverage of CVRx (CVRX) with Overweight Recommendation - MSN
CVRx (NASDAQ:CVRX) Stock Price Expected to Rise, Craig Hallum Analyst Says - MarketBeat
CVRx earns Medicare win for Barostim procedure - Mass Device
CVRx gains CMS payment classification for Barostim - Investing.com
CVRx Announces Positive Outpatient Payment for Barostim Procedure in 2025 - GlobeNewswire
CVRx, Inc. (NASDAQ:CVRX) Position Decreased by Emerald Advisers LLC - MarketBeat
Broadcom To Rally Around 18%? Here Are 10 Top Analyst Forecasts For MondayBroadcom (NASDAQ:AVGO) - Benzinga
Cvrx Inc (CVRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.82%
자본화:
|
볼륨(24시간):